Mountain Pacific Partners Invests $2M in Growth Capital into Alterra Medical
August 31, 2021
Mountain Pacific Partners announced its $2 million investment into Alterra Medical to support the rapid growth of this specialty healthcare distributor and commercialization engine. This announcement coincides with Alterra’s recent appointment of Jeff Hastings, former Senior Vice President and General Manager of Commercial Sales and Marketing at Owens & Minor, as Chief Executive Officer.
Alterra has assembled a seasoned executive team with decades of group purchasing organization (GPO), integrated delivery network (IDN), and government healthcare system expertise to rapidly expand and diversify its product portfolio.
“As Alterra continues to build on its roots as specialty distributor of electrophysiology and interventional cardiology products, this infusion of capital accelerates their investment into world-class internal sales, marketing, and logistics capabilities that will solidify their place in the healthcare value chain,” said Akhil Agrawal, Managing Partner at Mountain Pacific Partners.
Mountain Pacific Partners comprises a diverse partnership of entrepreneurs, operators, healthcare practitioners, government administrators, and legal professionals with a proven commercialization track record. The firm focuses on promoting health security and transforming healthcare delivery.
“Mountain Pacific Partners is our ideal investor,” said Hastings. “Like Alterra, their passion for innovation and commitment to expanding the base of critical healthcare products made in the US enables us to better serve our broad range of customers, including healthcare providers, commercial retail chains, the federal government and the general public.”
About Mountain Pacific Partners Mountain Pacific Partners is a Salt Lake City-based, life sciences investment firm. Their first fund focused on supporting life sciences innovation in the Mountain West and Asia. Currently, Mountain Pacific Partners is launching MPF II NOW, a fund focused on health security through reshoring of critical healthcare product manufacturing and reverse technology transfer, and MPF II NEXT, a fund focused on transforming healthcare delivery through innovative technology and medical devices.
To learn more, visit http://www.mountainpacificfund.com/.
Recent News
- bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
- DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY
- 2025 BIO International Recap
- Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
- Nelson Labs to Double Cleanroom Capacity to Support Growing Demand for Sterility Assurance Services
- RATIO THERAPEUTICS AND NUSANO ENTER LONG-TERM, MULTI-ISOTOPE SUPPLY AGREEMENT TO BOOST PRODUCTION OF CANCER RADIOPHARMACEUTICALS